Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Infliximab in Pediatric Inflammatory Bowel Disease: A Systematic Review and Revised Dosing Considerations
Conclusions:
Adult to pediatric weight–based dosing extrapolation is often inadequate. We provide several considerations for optimal dosing of IFX in children and adolescents with IBD.
Source: Journal of Pediatric Gastroenterology and Nutrition - Category: Gastroenterology Tags: Review Article Source Type: research
More News: Children | Clinical Trials | Gastroenterology | Inflammatory Bowel Disease | Nutrition | Pediatrics | Remicade | Study